CTOs on the Move

Austen Riggs Center

www.austenriggs.net

 
Austen Riggs Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in West Stockbridge, MA. To find more information about Austen Riggs Center, please visit www.austenriggs.net
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Cardium Therapeutics, Inc.

Cardium Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Cardium Therapeutics, Inc., please visit www.cardiumthx.com

MPLN, Molecular Pathology Laboratory Network

Personalized Molecular Pathology Laboratory Services Molecular Pathology Laboratory Network, Inc (MPLN) is a regional diagnostic laboratory specializing in oncology and women's health testing.

The Center for Healthcare Information and Analysis

Two things distinguish CHIA in our pursuit of improving the Massachusetts health care system: our public-interest perspective, and our unique data sets. Our perspective is rooted in our independence – our agenda and findings are not colored by the special interests of industry or politics – and in the talents and commitment of CHIA employees. CHIA`s mission is to be the agency of record for Massachusetts health care information, to responsibly steward sensitive and confidential data, and to objectively report reliable and meaningful information about the quality, affordability, utilization, access, and outcomes of the Massachusetts health care system. We pursue this mission in the public interest. This informs our objective perspective, and our commitment to serving a broad, diverse audience. We are a hub, connecting our products to policymakers, public and private payers and providers, employers, researchers, and the residents of Massachusetts. Our vision is a transparent health care system where reliable information provides common ground for improvement and empowers people and organizations to make informed decisions.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Lima Area Agency On Aging

Lima Area Agency On Aging is a Lima, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.